After removing the noise from Hemoglobin, your signal is so much clearer!
Hemoglobin accounts for more than 95 percent of the protein mass in erythrocytes, and is often an interfering factor for many types of analysis. With the rising use of dried blood cards and point-of-care devices, analytical interferences from hemoglobin continues to present problems.
This white paper describes a variety of Biotech Support Group products for hemoglobin removal along with some definitive examples of how hemoglobin depletion improved the value of research studies. Successful uses are described for diseases such as malaria and Parkinson's disease, as well as drug-target interactions and post-translational modifications discovered from erythrocyte proteomes.
Offered Free by: Biotech Support Group LLC
See All Resources from: Biotech Support Group LLC
This download should complete shortly. If the resource doesn't automatically download, please, click here.